.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
A randomized controlled trial in India evaluated prophylactic tranexamic acid before cesarean delivery among women at high risk of postpartum hemorrhage. The study found reduced calculated blood loss with tranexamic acid compared with placebo, supporting its potential role in prevention alongside established obstetric hemorrhage protocols. For clinicians, the important distinction is between prophylaxis in selected high-risk patients and treatment of established PPH, where urgent therapeutic administration remains time-sensitive. Risk assessment should include placenta-related bleeding risk, anemia, previous PPH, multiple gestation and other clinical factors. Tranexamic acid does not replace uterotonics, blood-bank preparedness or mechanical and surgical measures when bleeding is severe. The trial is particularly relevant to practical protocol development because it demonstrates how a relatively simple pharmacologic intervention can be incorporated into cesarean pathways. Local guidelines and contraindications should always be considered when applying prophylactic strategies.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A randomized controlled trial in India evaluated prophylactic tranexamic acid before cesarean delivery among women at high risk of postpartum hemorrhage. The study found reduced calculated blood loss with tranexamic acid compared with placebo, supporting its potential role in prevention alongside established obstetric hemorrhage protocols. For clinicians, the important distinction is between prophylaxis in selected high-risk patients and treatment of established PPH, where urgent therapeutic administration remains time-sensitive. Risk assessment should include placenta-related bleeding risk, anemia, previous PPH, multiple gestation and other clinical factors. Tranexamic acid does not replace uterotonics, blood-bank preparedness or mechanical and surgical measures when bleeding is severe. The trial is particularly relevant to practical protocol development because it demonstrates how a relatively simple pharmacologic intervention can be incorporated into cesarean pathways. Local guidelines and contraindications should always be considered when applying prophylactic strategies.
4 weeks back
Explore the therapeutic promise of TLR7 and TLR8 inhibitors in managing systemic lupus erythematosus and monogenic autoimmune diseases. Learn how targeting endolysosomal single-stranded RNA sensing and regulatory checkpoints like UNC93B1 and PLD4 offers precision treatment without broad immunosuppression.
Yesterday
Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
3 weeks back
Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
Yesterday
A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
Yesterday
Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
2 days back
